These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10579830)

  • 1. Discovery of novel non-peptide CCR1 receptor antagonists.
    Ng HP; May K; Bauman JG; Ghannam A; Islam I; Liang M; Horuk R; Hesselgesser J; Snider RM; Perez HD; Morrissey MM
    J Med Chem; 1999 Nov; 42(22):4680-94. PubMed ID: 10579830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor.
    Hesselgesser J; Ng HP; Liang M; Zheng W; May K; Bauman JG; Monahan S; Islam I; Wei GP; Ghannam A; Taub DD; Rosser M; Snider RM; Morrissey MM; Perez HD; Horuk R
    J Biol Chem; 1998 Jun; 273(25):15687-92. PubMed ID: 9624164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.
    Chou CC; Fine JS; Pugliese-Sivo C; Gonsiorek W; Davies L; Deno G; Petro M; Schwarz M; Zavodny PJ; Hipkin RW
    Br J Pharmacol; 2002 Nov; 137(5):663-75. PubMed ID: 12381680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor.
    Liang M; Rosser M; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Kretschmer PJ; Pu H; Dunning L; Snider RM; Morrissey MM; Hesselgesser J; Perez HD; Horuk R
    Eur J Pharmacol; 2000 Feb; 389(1):41-9. PubMed ID: 10686294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.
    Onuffer J; McCarrick MA; Dunning L; Liang M; Rosser M; Wei GP; Ng H; Horuk R
    J Immunol; 2003 Feb; 170(4):1910-6. PubMed ID: 12574358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
    J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and discovery of a novel CCR1 antagonist.
    Naya A; Sagara Y; Ohwaki K; Saeki T; Ichikawa D; Iwasawa Y; Noguchi K; Ohtake N
    J Med Chem; 2001 Apr; 44(9):1429-35. PubMed ID: 11311066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
    Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
    J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
    Pease JE; Wang J; Ponath PD; Murphy PM
    J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model.
    Horuk R; Shurey S; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Buckman B; Wei GP; Xu W; Liang M; Rosser M; Dunning L; Hesselgesser J; Snider RM; Morrissey MM; Perez HD; Green C
    Immunol Lett; 2001 Apr; 76(3):193-201. PubMed ID: 11306147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR1 chemokine receptor antagonist.
    Saeki T; Naya A
    Curr Pharm Des; 2003; 9(15):1201-8. PubMed ID: 12769747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver.
    Ajuebor MN; Hogaboam CM; Le T; Proudfoot AE; Swain MG
    Eur J Immunol; 2004 Oct; 34(10):2907-18. PubMed ID: 15368307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases.
    Furuichi K; Wada T; Sakai N; Iwata Y; Yoshimoto K; Shimizu M; Kobayashi K; Takasawa K; Kida H; Takeda SI; Mukaida N; Matsushima K; Yokoyama H
    Am J Nephrol; 2000; 20(4):291-9. PubMed ID: 10970982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
    Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
    Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel series of human CCR1 antagonists.
    Xie YF; Sircar I; Lake K; Komandla M; Ligsay K; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Sakurai N; Barbosa M; Jack R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2215-21. PubMed ID: 18329267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic activation of alternative CCR1 ligands in inflammation.
    Berahovich RD; Miao Z; Wang Y; Premack B; Howard MC; Schall TJ
    J Immunol; 2005 Jun; 174(11):7341-51. PubMed ID: 15905581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of C-C chemokine receptor 1 (CCR1) as the monocyte hemofiltrate C-C chemokine (HCC)-1 receptor.
    Tsou CL; Gladue RP; Carroll LA; Paradis T; Boyd JG; Nelson RT; Neote K; Charo IF
    J Exp Med; 1998 Aug; 188(3):603-8. PubMed ID: 9687537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
    Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
    Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.